Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis
出版年份 2021 全文链接
标题
Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis
作者
关键词
-
出版物
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Volume 69, Issue 35, Pages 10121-10137
出版商
American Chemical Society (ACS)
发表日期
2021-08-21
DOI
10.1021/acs.jafc.1c03279
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ginsenoside Rk3 Ameliorates Obesity-Induced Colitis by Regulating of Intestinal Flora and the TLR4/NF-κB Signaling Pathway in C57BL/6 Mice
- (2021) Hongwei Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Therapeutic modulation methods of gut microbiota and gut-liver axis
- (2021) Ayfer Beyaz Coşkun et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Advances in resection and transplantation for hepatocellular carcinoma
- (2020) Eric Vibert et al. JOURNAL OF HEPATOLOGY
- Gut microbiome in HCC – Mechanisms, diagnosis and therapy
- (2020) Robert F. Schwabe et al. JOURNAL OF HEPATOLOGY
- Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice
- (2020) Yanyan Zhu et al. PHARMACOLOGICAL RESEARCH
- Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events
- (2020) Jian-Feng Huang et al. PHARMACOLOGICAL RESEARCH
- Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
- (2020) Shasha He et al. Frontiers in Pharmacology
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
- (2020) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Gut microbiome, liver immunology, and liver diseases
- (2020) Rui Wang et al. Cellular & Molecular Immunology
- Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
- (2020) Chathur Acharya et al. GASTROENTEROLOGY
- Systemic Treatment for Advanced Hepatocellular Carcinoma
- (2019) Mohamed Bouattour et al. Liver Cancer
- The microbiome, cancer, and cancer therapy
- (2019) Beth A. Helmink et al. NATURE MEDICINE
- Protective effects of ginsenoside Rk3 against chronic alcohol-induced liver injury in mice through inhibition of inflammation, oxidative stress, and apoptosis
- (2019) Linlin Qu et al. FOOD AND CHEMICAL TOXICOLOGY
- Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation
- (2019) Xiaoming Fan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neuroprotective Effects of Ginsenoside Rg1 against Hyperphosphorylated Tau-Induced Diabetic Retinal Neurodegeneration via Activation of IRS-1/Akt/GSK3β Signaling
- (2019) Ying Ying et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer
- (2019) Yannan Liu et al. BIOCHEMICAL PHARMACOLOGY
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis
- (2019) Zhigang Ren et al. Small
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease
- (2018) Francesca Romana Ponziani et al. HEPATOLOGY
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
- (2018) Zhigang Ren et al. GUT
- Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model
- (2018) Yannan Liu et al. Food & Function
- Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals
- (2018) Bonggi Lee et al. Journal of Immunology Research
- Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
- (2017) Andrea Notarpaolo et al. JOURNAL OF HEPATOLOGY
- The gut microbiome and liver cancer: mechanisms and clinical translation
- (2017) Le-Xing Yu et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome and liver diseases
- (2016) Herbert Tilg et al. GUT
- Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease
- (2015) Aaron Lerner et al. AUTOIMMUNITY REVIEWS
- The gut microbiota and host health: a new clinical frontier
- (2015) Julian R Marchesi et al. GUT
- Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases
- (2015) Bidisha Paul et al. Clinical Epigenetics
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- 20S-dihydroprotopanaxadiol, a ginsenoside derivative, boosts innate immune responses of monocytes and macrophages
- (2013) Mi-Yeon Kim et al. Journal of Ginseng Research
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Structural Analyses of Human Toll-like Receptor 4 Polymorphisms D299G and T399I
- (2012) Umeharu Ohto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis
- (2011) Ekihiro Seki et al. HEPATOLOGY RESEARCH
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
- (2010) João-Bruno Soares et al. Hepatology International
- Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
- (2009) J G Fox et al. GUT
- Targeted therapy for hepatocellular carcinoma
- (2009) Hans Christian Spangenberg et al. Nature Reviews Gastroenterology & Hepatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started